Home › Funds › Boston Trust Walden Corp › JNJ

Boston Trust Walden Corp position in JNJ

JOHNSON & JOHNSON · Health Care

Boston Trust Walden Corp reported holding 538,379 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$142.5M, representing 1.15% of its reported portfolio and ranking #9 among its reported holdings. Boston Trust Walden Corp has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)538.38K sh
Reported value held$142.53M
Portfolio Weight1.15%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Boston Trust Walden Corp's JNJ position evolved

Boston Trust Walden Corp first disclosed a stake in JNJ in Q3 2023 at 1,029,462 shares (US$160.3M). The position peaked in Q1 2025 at 1,092,003 shares, worth US$181.1M. Across 13 filings, Boston Trust Walden Corp increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 538,379 shares valued at US$142.5M — a reduction of -42,454 shares quarter over quarter.. Notable position changes include a 30% trim in Q3 2025 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.03M $160.34M New
Q4 2023 1.05M $164.37M Add
Q1 2024 1.06M $168.16M Add
Q2 2024 1.02M $149.77M Reduce
Q3 2024 1.09M $177.25M Add
Q4 2024 1.09M $157.01M Reduce
Q1 2025 1.09M $181.10M Add
Q2 2025 1.01M $154.96M Reduce
Q3 2025 714.59K $132.50M Reduce
Q4 2025 668.63K $138.37M Reduce
Q1 2026 594.06K $145.21M Reduce
Q2 2026 580.83K $147.51M Reduce
Q3 2026 538.38K $142.53M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Boston Trust Walden Corp held JNJ?

Boston Trust Walden Corp has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Boston Trust Walden Corp's current position in JNJ?

As of Q3 2026, Boston Trust Walden Corp holds 538.38K shares of JNJ (JOHNSON & JOHNSON), valued at $142.53M, representing 1.15% of its reported portfolio and ranking #9.

Has Boston Trust Walden Corp been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Boston Trust Walden Corp reduced its position in JNJ. The position peaked in Q1 2025 at 1.09M shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.